Citigroup »

Alterity Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Alterity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alterity Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alterity Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-09-30 $155 43 3.63

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Citigroup

Top funds holding Alterity Therapeutics

Twin Lakes Capital Management
Greenleaf Trust
HB Wealth Management
Citadel Advisors
Hrt Financial
Bnp Paribas Arbitrage, Snc
Rhumbline Advisers
Acadian Asset Management
GAMMA Investing
Farther Finance Advisors
Providence Capital Advisors
Advisor Group Holdings
Citigroup
Ronald Blue Trust
CoreCap Advisors

View all funds holding Alterity Therapeutics